Overcoming Barriers to Use of SGLT2 Inhibitor Therapy
Stephen J. Greene, Jacob B. Pierce
Topics & Concepts
PolypharmacyDapagliflozinMedicineEjection fractionHeart failurePlaceboComorbidityInternal medicineConcomitantAdverse effectIntensive care medicineDiabetes mellitusType 2 diabetesEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementHeart Failure Treatment and ManagementPotassium and Related Disorders